Join to view full profile
5169 South Cottonwood StreetSuite 400Murray, UT 84107
Phone+1 801-507-3472
Fax+1 801-507-3471
Dr. Coudreaut is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1990 - 1994
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990
Certifications & Licensure
CA State Medical License 1991 - Present
NH State Medical License 1999 - Present
UT State Medical License 1994 - 2028
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HELP2 Clinical Desktop, Intermountain Healthcare, 2014, 2016
Publications & Presentations
PubMed
- When Tapering Is Not an Option: Transitioning From High-Dose Methadone to Buprenorphine.Sarah Petelinsek, Jarom Morris, Ethan Zaugg, Michael Coudreaut
Cureus. 2026-08-01 - 15 citationsPharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.Donald D. Chang, Harris A. Eyreeuro, Ryan Abbott, Michael Coudreaut, Bernhard T. Baune
Pharmacogenomics. 2018-11-01 - 55 citationsSleep disordered breathing in patients receiving therapy with buprenorphine/naloxoneRobert J. Farney, Amanda M McDonald, Kathleen M. Boyle, Gregory L. Snow, Robert T. Nuttall
The European Respiratory Journal. 2013-08-01
Press Mentions
Companies Tout Psychiatric Pharmacogenomic Testing, but Is It Ready for a Store near You?October 3rd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
